Vertical transmission of Group B Streptococcus in a public referral hospital
This study conducted in Goiânia, Brazil, reveals a high rate of maternal Group B Streptococcus colonization and vertical transmission alongside significant resistance to macrolides and lincosamides, underscoring the critical need for routine prenatal screening and the continued use of β-lactams for intrapartum prophylaxis while highlighting qPCR as a sensitive diagnostic alternative.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every year, millions of babies around the world face a silent threat before they even take their first breath. This threat comes from a common bacterium called Group B Streptococcus, often shortened to GBS. For most adults, this germ lives harmlessly in the digestive or urinary tracts, causing no trouble at all. But for a newborn, whose immune system is still learning how to fight, the same bacterium can be devastating. If a mother carries the germ, she can pass it to her baby during birth. Once inside the baby, it can cause severe infections like pneumonia, blood poisoning, or inflammation of the brain. While doctors have known for decades that this transmission happens, the exact frequency and the best ways to stop it vary greatly depending on where in the world a family lives. In many places, the lack of clear data makes it difficult to create rules that protect every child.
In a public hospital in Goiânia, Brazil, a team of researchers set out to map this invisible danger in their own community. They wanted to know how many pregnant women carried the germ, how often it was passed to their babies, and whether the bacteria were becoming harder to kill with common medicines. The team studied 206 mothers and their newborns over a three-month period in late 2024. Instead of relying on just one way to find the bacteria, they used two different methods: a traditional culture test, which grows the germ in a lab dish, and a modern molecular test that looks for the genetic fingerprint of the bacteria. They also checked which antibiotics the bacteria could resist, a crucial step for choosing the right medicine if an infection occurs.
The results revealed a situation that demands attention. The researchers found that more than one in four of the mothers they studied were carrying the bacteria, even though most of them felt perfectly healthy. When they looked at the babies, they discovered that the germ had moved from mother to child in nearly two out of every three cases where the mother was infected. This means that a significant number of newborns in this hospital were being exposed to a dangerous pathogen simply by being born. The study also highlighted a gap in detection. The traditional culture method, which is the standard way doctors usually check for this germ, missed a portion of the infected mothers. The newer molecular test found more cases, suggesting that relying on the old method alone might leave some families without the protection they need.
Beyond how often the germ spreads, the study uncovered a worrying trend in how the bacteria respond to medicine. The researchers tested the bacteria against several types of antibiotics. They found that the germ remained vulnerable to a specific family of drugs known as beta-lactams, which include penicillin and ampicillin. These medicines worked well, confirming they are still the best choice for preventing infection during labor. However, the bacteria showed high resistance to other common antibiotics, such as tetracycline, erythromycin, and clindamycin. This is a significant problem because these other drugs are often used as alternatives for mothers who are allergic to penicillin. If a mother cannot take penicillin and the bacteria are resistant to the backup options, the risk of passing the infection to the baby increases.
The study also looked closely at the mothers to see if certain factors made them more likely to carry the germ or pass it on. They examined age, education, marital status, and medical history, including conditions like diabetes or high blood pressure. Surprisingly, none of these factors showed a clear link to whether a mother carried the bacteria or whether she passed it to her child. The germ appeared to be present across all groups, affecting young and older mothers, those with more or less education, and those with or without other health issues. This suggests that the risk is widespread and not limited to a specific type of person, reinforcing the idea that screening should be a routine part of care for everyone.
The findings from this hospital in Brazil add a vital piece to the global puzzle of newborn health. They show that the rate of infection in this region is high, matching patterns seen in other parts of the world where prenatal care is less accessible. The high rate of vertical transmission—the passing of the germ from mother to child—underscores the urgency of finding every carrier before the baby is born. The study suggests that while the traditional lab test is useful, adding a faster, more sensitive genetic test could help doctors catch more cases early. Most importantly, the data confirms that while some medicines are failing, the primary treatments remain effective. By identifying the germ early and using the right antibiotics, hospitals can continue to protect newborns from a threat that is common, silent, and entirely preventable.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.